Fairmount Funds Management LLC Top Holdings and 13F Report (2021) About Fairmount Funds Management LLCInvestment ActivityFairmount Funds Management LLC has $771.90 million in total holdings as of September 30, 2021.Fairmount Funds Management LLC owns shares of 17 different stocks, but just 10 companies or ETFs make up 80% of its holdings.Approximately 14.05% of the portfolio was purchased this quarter.About 1.32% of the portfolio was sold this quarter.This quarter, Fairmount Funds Management LLC has purchased 15 new stocks and bought additional shares in 5 stocks.Fairmount Funds Management LLC sold shares of 0 stocks and completely divested from 1 stock this quarter.Largest Holdings APOGEE THERAPEUTICS INC $88,972,739Axsome Therapeutics $85,096,223Enliven Therapeutics $74,451,567Scholar Rock $64,607,178SPYRE THERAPEUTICS INC $60,150,972 Largest New Holdings this Quarter 008064206 - JADE BIOSCIENCES INC $32,171,476 HoldingG2545C104 - CRESCENT BIOPHARMA INC. $22,400,157 Holding23284F105 - CytomX Therapeutics $8,845,241 Holding Largest Purchases this Quarter JADE BIOSCIENCES INC 3,220,368 shares (about $32.17M)CRESCENT BIOPHARMA INC. 1,387,866 shares (about $22.40M)KINIKSA PHARMACEUTICALS INTL 670,591 shares (about $18.56M)Scholar Rock 450,000 shares (about $15.94M)Enliven Therapeutics 508,646 shares (about $10.20M) Sector Allocation Over TimeMap of 500 Largest Holdings ofFairmount Funds Management LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorAPOGEE THERAPEUTICS INC$88,972,7390.0%2,048,64711.5%COMAXSMAxsome Therapeutics$85,096,2230.0%815,17611.0%MedicalELVNEnliven Therapeutics$74,451,567$10,203,439 ▲15.9%3,711,4449.6%MedicalSRRKScholar Rock$64,607,178$15,939,000 ▲32.8%1,824,0318.4%MedicalSPYRE THERAPEUTICS INC$60,150,9720.0%4,018,1017.8%COM NEWNUVLNuvalent$55,513,0570.0%727,5637.2%MedicalDIANTHUS THERAPEUTICS INC$50,434,968$121,095 ▲0.2%2,707,1916.5%COMKINIKSA PHARMACEUTICALS INTL$49,054,455$18,555,253 ▲60.8%1,772,8396.4%ORD SHS CL AVRDNViridian Therapeutics$48,369,584$197,118 ▲0.4%3,459,9136.3%MedicalCOGTCogent Biosciences$44,700,1020.0%6,225,6415.8%MedicalORUKA THERAPEUTICS INC$37,799,2460.0%3,371,9224.9%COMJADE BIOSCIENCES INC$32,171,476$32,171,476 ▲New Holding3,220,3684.2%COM NEWCRESCENT BIOPHARMA INC.$22,400,157$22,400,157 ▲New Holding1,387,8662.9%COMATXSAstria Therapeutics$19,050,1310.0%3,554,1292.5%MedicalZENAS BIOPHARMA INC$18,341,2900.0%1,892,8062.4%COMIKTInhibikase Therapeutics$11,943,7500.0%6,125,0001.5%MedicalCTMXCytomX Therapeutics$8,845,241$8,845,241 ▲New Holding3,896,5821.1%MedicalBICARA THERAPEUTICS INC$0$10,217,735 ▼-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access